✦ LIBER ✦

HIV-1 genetic diversity and drug resistance among treatment naïve patients from Southern Brazil: An association of HIV-1 subtypes with exposure categories

✍ Scribed by Tiago Gräf; Caroline P.B. Passaes; Luis G.E. Ferreira; Edmundo C. Grisard; Mariza G. Morgado; Gonzalo Bello; Aguinaldo R. Pinto

Book ID: 116632090
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 661 KB
Volume: 51
Category: Article
ISSN: 1386-6532
DOI: 10.1016/j.jcv.2011.04.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary HIV-1 drug resistance in the C-t

Primary HIV-1 drug resistance in the C-terminal domains of viral reverse transcriptase among drug-naïve patients from Southern Brazil

✍ André F. Santos; Jussara Silveira; Cláudia P. Muniz; Michele Tornatore; Lívia R. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Analysis of the diversity of the HIV-1 p

Analysis of the diversity of the HIV-1 pol gene and drug resistance associated changes among drug-naïve patients in Burkina Faso

✍ Denis M. Tebit; Lassana Sangaré; Fabrice Tiba; Yameogo Saydou; Aline Makamtse; H 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB

## Abstract A cross‐sectional study was undertaken among drug‐naïve HIV patients at the University Hospital in Ouagadougou shortly before and after the introduction of large‐scale antiretroviral therapy (ART) in Burkina Faso. Baseline clinical and virological data as well as protease (PR) and 5′ re

Moderate prevalence of transmitted drug

Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil

✍ Adriana Santarém Ferreira; Ludimila Paula Vaz Cardoso; Mariane Martins de Araújo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## Abstract Few reports have described the molecular characteristics of the AIDS epidemic within the interior regions of Brazil, a country of continental dimensions. To help fill this gap, the prevalence of transmitted antiretroviral drug resistance and human immunodeficiency virus type 1 (HIV‐1) d